Literature DB >> 6618018

Diabetes mellitus in Hopi and Navajo indians. Prevalence of microvascular complications.

R G Rate, W C Knowler, H G Morse, M D Bonnell, J McVey, C L Chervenak, M G Smith, G Pavanich.   

Abstract

In a cross-sectional study of Hopi and Navajo Indians with non-insulin-dependent diabetes mellitus, we found vascular complications to be strongly related to the duration of diabetes. In patients with diabetes of at least 10 yr duration, retinopathy was found in 57%, nephropathy in 40%, peripheral neuropathy in 21%, and peripheral vascular disease in 28%. For the Hopi and Navajo, the duration-specific prevalence rates of microvascular disease were very similar to prevalence rates found in many other populations. Thus we question the concept, based on reports in the late 1960s, that the Hopi and Navajo Indians have hyperglycemia as an isolated chemical abnormality unaccompanied by other manifestations of diabetes mellitus.

Entities:  

Mesh:

Year:  1983        PMID: 6618018     DOI: 10.2337/diab.32.10.894

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  The epidemiology of atherosclerosis and its risk factors among Native Americans.

Authors:  James M Galloway
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 2.  The prevalence of diabetic neuropathy according to ethnicity.

Authors:  Jay M Sosenko
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

3.  Genetic Epidemiologic Analysis of Hypertensive Retinopathy in an Underrepresented and Rare Federally Recognized Native American Population of the Intermountain West.

Authors:  Patrice M Hicks; Samuel A Collazo Melendez; Albert Vitale; William Self; Mary Elizabeth Hartnett; Paul Bernstein; Denise J Morgan; Michael Feehan; Akbar Shakoor; Ivana Kim; Leah A Owen; Margaret M DeAngelis
Journal:  J Community Med Public Health       Date:  2019-06-10

4.  The changing epidemiology of diabetes mellitus among Navajo Indians.

Authors:  J R Sugarman; M Hickey; T Hall; D Gohdes
Journal:  West J Med       Date:  1990-08

5.  Diabetes in part-aborigines of Western Australia.

Authors:  K G Stanton; V McCann; M Knuiman; I J Constable; T Welborn
Journal:  Diabetologia       Date:  1985-01       Impact factor: 10.122

6.  Oral glucose tolerance and ambient temperature in non-diabetic subjects.

Authors:  A O Akanji; M Bruce; K Frayn; T D Hockaday; G M Kaddaha
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

7.  Antiproliferative effect of fluvastatin and thiazolidinedione in mesangial cells of diabetic rats.

Authors:  Mitsuru Okada; Hidehiko Yanagida; Hiroaki Kuwajima; Tsukasa Takemura
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

8.  Prevalence of diabetes in a Navajo Indian community.

Authors:  J Sugarman; C Percy
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

9.  Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan.

Authors:  R F Dyck; L Tan
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

10.  Prevalence of diabetic and atherosclerotic complications among Mohawk Indians of Kahnawake, PQ.

Authors:  A C Macaulay; L T Montour; N Adelson
Journal:  CMAJ       Date:  1988-08-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.